Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Significance: Cancer stem cells (CSCs) exhibit enhanced chemo/radiotherapy resistance, and their survival following cancer treatment is believed to be responsible for tumor recurrence and metastasis. Thus, understanding the mechanisms through which CSCs survive conventional chemotherapy is essential for identification of new therapeutic strategies to prevent tumor relapse. Our findings that ovarian CSCs survive cisplatin treatment through elevated expression of polymerase η represent an opportunity to eradicate CSCs and improve the survival of ovarian cancer patients. In addition, identification of miR-93 as the regulator of polymerase η expression provides a target to increase the efficacy of cisplatin treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recently, this DNA polymerase was shown to be induced in several human cell lines after treatment with chemotherapeutic agents in a p53-dependent manner, and was linked to acquired resistance to chemotherapy ( 24 , 25 ).”
From Predominant role of DNA polymerase eta and p53-dependent translesion synthesis in the survival of ultraviolet-irradiated human cells (2017) · cites this paper as [25]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The upregulation of miR-93, a microRNA that triggers pol η degradation, also enhanced the effect of cisplatin [110]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [110]
Experimental — accuracy not yet measuredIn the citing paper
“The protective role of TLS in cancer is revealed by the overexpression of pol η in ovarian-cancer cells, which is evidenced in populations that resist cisplatin treatment [110]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [110]
In the citing paper
“The protective role of TLS in cancer is revealed by the overexpression of pol η in ovarian-cancer cells”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [110]
In the citing paper
“The effect of cisplatin was enhanced when simultaneously depleting pol η in ovarian-cancer-cell models [110]”
From CDK-Independent and PCNA-Dependent Functions of p21 in DNA Replication (2020) · cites this paper as [110]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Siegel, R., Ma, J., Zou, Z., & Jemal, A. (2014) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21208 · Cited by 11,499
Signet-Ring Cell Carcinoma of the Colon: A Case Report and Review of the Literature
Park, P. Y., Goldin, T., Chang, J., Markman, M., & Kundranda, M. N. (2015) · Case Reports in Oncology · doi:10.1159/000441772 · Cited by 5,273
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C. J., Jamieson, C. H. M., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. M. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,051 · cited 1×
“The CD44CD117 cells, SP cells, ALDH cells, and spheroid cells isolated from both ovarian cancer cell lines and primary human ovarian tumors fulfill all currently accepted criteria for the existence of a subpopulation of tumor-initiating cells (19, 22, 23).”
BackgroundDirect Cellular Responses to Platinum-Induced DNA Damage
Jung, Y., & Lippard, S. J. (2007) · Chemical Reviews · doi:10.1021/cr068207j · Cited by 1,391 · cited 1×
“These cross-links block DNA replication and invoke apoptosis in rapidly dividing cells (5).”
BackgroundIdentification and Characterization of Ovarian Cancer-Initiating Cells from Primary Human Tumors
Zhang, S., Balch, C., Chan, M. W., Lai, H.-C., Matei, D., Schilder, J. M., Yan, P. S., Huang, T. H.-M., & Nephew, K. P. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0364 · Cited by 1,293 · cited 15×
“Ovarian CSCs have been successfully isolated, based on the expression of distinctive cell surface markers CD44 and CD117 (18, 19), their ability to efflux the Hoechst 33342 fluorescent dye (Side population, SP) (20), the activity of ALDH (21), and their ability to grow as floating spheres in serum-free medium (19).”
BackgroundMethodInfluentialCancer Stem Cells: Models and Concepts
Dalerba, P., Cho, R. W., & Clarke, M. F. (2007) · Annual Review of Medicine · doi:10.1146/annurev.med.58.062105.204854 · Cited by 1,274 · cited 1×
“The CD44CD117 cells, SP cells, ALDH cells, and spheroid cells isolated from both ovarian cancer cell lines and primary human ovarian tumors fulfill all currently accepted criteria for the existence of a subpopulation of tumor-initiating cells (19, 22, 23).”
BackgroundCancer stem cells: an evolving concept
Nguyen, L. V., Vanner, R., Dirks, P., & Eaves, C. J. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3184 · Cited by 1,171 · cited 1×
“Thus, this reduced expression of MCM7, probably due to relative quiescence of CSCs (49, 50), could be a contributor to the decreased expression of miR-93 in CSCs.”
BackgroundOvarian cancer: strategies for overcoming resistance to chemotherapy
Agarwal, R., & Kaye, S. B. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1123 · Cited by 1,154 · cited 2×
“Cancer Chemother Pharmacol 39(3):245–253.”
BackgroundSide Population in Human Lung Cancer Cell Lines and Tumors Is Enriched with Stem-like Cancer Cells
Ho, M. M., Ng, A. V., Lam, S., & Hung, J. Y. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3557 · Cited by 947 · cited 1×
“Although MCM7 overexpression has been identified in various tumors and considered a bad prognostic indicator in prostate cancer (45, 46), MCM7 expression is lower in various CSCs, including SP of human lung cancer cells (47) and prostate cancer cells (48), as well as ALDH+ breast cancer cells (41).”
BackgroundMechanisms of resistance to cisplatin
Kartalou, M., & Essigmann, J. M. (2001) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(01)00141-5 · Cited by 869 · cited 6×
“Among many polymerases tested in vitro, the Y-family DNA Pol η is the most efficient and accurate at bypassing Pt-GG lesions (10, 37, 38).”
MethodInfluential
Cited by
Zhou, H.-M., Zhang, J.-G., Zhang, X., & Li, Q. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00430-1 · Cited by 472
“Srivastava found that enhanced expression of DNA polymerase contributes to cisplatin resistance in ovarian CSCs.(135) In contrast, pharmacological inhibition of the DNA damage checkpoints CHK1 and CHK2 sensitized CSCs to radiotherapy.”
BackgroundSelf-citationDNA repair pathways and cisplatin resistance: an intimate relationship
Rocha, C. R. R., Silva, M. M., Quinet, A., Cabral-Neto, J. B., & Menck, C. F. M. (2018) · Clinics · doi:10.6061/clinics/2018/e478s · Cited by 446
“A recent report showed elevated PolZ expression in ovarian cancer stem cells isolated from ovarian cancer cell lines and primary tumors (77).”
BackgroundAdvances in Toxicological Research of the Anticancer Drug Cisplatin
Qi, L., Luo, Q., Zhang, Y., Jia, F., Zhao, Y., & Wang, F. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00204 · Cited by 440
Vitale, I., Manic, G., De Maria, R., Kroemer, G., & Galluzzi, L. (2017) · Molecular Cell · doi:10.1016/j.molcel.2017.04.006 · Cited by 361
“Accordingly, genetic inhibition of POLH by small interfering RNAs (siRNAs) or microRNAs (miRNAs) reportedly sensitizes ovarian CSCs to the genotoxic effects of cisplatin, in vitro and in vivo (Srivastava et al., 2015) (Figure 2).”
BackgroundNon-coding RNAs and potential therapeutic targeting in cancer
Toden, S., Zumwalt, T. J., & Goel, A. (2021) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188491 · Cited by 327
Metadata
- Authors
- Srivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E.
- Affiliations
- Department of Radiology,
- Department of Molecular Virology, Immunology and Medical Genetics,
- Comprehensive Cancer Center,
- Department of Pathology,
- Center for Biostatistics, and
- The Ohio State University (US)
- ORCID
- Venue
- Proceedings of the National Academy of Sciences
- Publisher
- National Academy of Sciences
- Published
- 2015-03-23
- Volume
- 112
- Issue
- 14
- Pages
- 4411-4416
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- PMC
- PMC4394248
- OpenAlex
- W2035233698
- Cited by
- 188
- References
- 51
- Citations by year
- 2026: 7 · 2025: 14 · 2024: 9 · 2023: 18 · 2022: 16 · 2021: 14 · 2020: 22 · 2019: 18 · 2018: 23 · 2017: 20 · 2016: 20 · 2015: 7
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Proceedings of the National Academy of Sciences (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Health (CA151248)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
- Keywords
- DNA polymerase eta, cisplatin resistance, ovarian cancer stem cells, translesion synthesis, chemoresistance, miR-93, apoptosis, tumor recurrence, DNA damage response
- MeSH terms
- Y-Family DNA Polymerases, Animals, Cell Survival, Cisplatin, DNA, DNA Damage, DNA-Directed DNA Polymerase, DNA Repair, Female, Flow Cytometry, Humans, Mice, Nude, Neoplasm Metastasis, Neoplasm Recurrence, Local, Neoplasm Transplantation, Ovarian Neoplasms, Recurrence, Neoplastic Stem Cells, Down-Regulation, MicroRNAs, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. https://app.cochat.ai/papers/10.1073/pnas.1421365112
- The paper
- Srivastava, A. K., Han, C., Zhao, R., Cui, T., Dai, Y., Mao, C., Zhao, W., Zhang, X., Yu, J., & Wang, Q.-E. (2015). Enhanced expression of DNA polymerase eta contributes to cisplatin resistance of ovarian cancer stem cells. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.1421365112
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.